MABC171
抗-异柠檬酸脱氢酶1（IDH1）-R132H抗体，克隆HMab-1
clone HMab-1, from mouse
别名:
Isocitrate dehydrogenase [NADP] cytoplasmic, IDH, Cytosolic NADP-isocitrate dehydrogenase, IDP, NADP(+)-specific ICDH, Oxalosuccinate decarboxylase
登录 查看组织和合同定价。
选择尺寸
关于此项目
UNSPSC Code:
12352203
NACRES:
NA.41
eCl@ss:
32160702
Conjugate:
unconjugated
Clone:
HMab-1, monoclonal
Application:
immunocytochemistry
immunohistochemistry
western blot
immunohistochemistry
western blot
Species reactivity:
human
Citations:
5
Technique(s):
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable
immunohistochemistry: suitable
western blot: suitable
Uniprot accession no.:
产品名称
抗-异柠檬酸脱氢酶1（IDH1）-R132H抗体，克隆HMab-1, clone HMab-1, from mouse
biological source
mouse
conjugate
unconjugated
antibody form
purified immunoglobulin
antibody product type
primary antibodies
clone
HMab-1, monoclonal
species reactivity
human
technique(s)
immunocytochemistry: suitable
immunohistochemistry: suitable
western blot: suitable
isotype
IgG1κ
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
unmodified
Quality Level
Gene Information
human ... IDH1(3417)
Analysis Note
对照
MBP标记的重组异柠檬酸脱氢酶1（IDH1）
MBP标记的重组异柠檬酸脱氢酶1（IDH1）
通过蛋白质印迹法在MBP标记的重组异柠檬酸脱氢酶1（IDH1）中进行评估。
蛋白质印迹分析：该抗体以1:500稀释度在WB中检测到MBP标记的重组异柠檬酸脱氢酶1（IDH1）。
蛋白质印迹分析：该抗体以1:500稀释度在WB中检测到MBP标记的重组异柠檬酸脱氢酶1（IDH1）。
Application
使用该抗异柠檬酸脱氢酶1（IDH1）-R132H抗体（克隆HMab-1，经验证可用于蛋白质印迹、IHC、ICC）检测异柠檬酸脱氢酶1（IDH1）-R132H。
研究子类别
凋亡 - 附加
凋亡 - 附加
研究类别
细胞凋亡 & 癌症
细胞凋亡 & 癌症
蛋白质印迹分析：该抗体的一个代表性批次在一组野生型和突变的重组IDH1蛋白中检测到异柠檬酸脱氢酶1（IDH1）-R132S。
免疫组织化学分析：一个来自独立实验室的代表性批次在间变性和弥漫性星形细胞瘤组织和原发性胶质母细胞瘤组织中检测到异柠檬酸脱氢酶1（IDH1）-R132S（Kato，Y.，et al.（2009）.Biochem Biophys Res Commun.390（3）:547-51）。
免疫组织化学分析：一个来自独立实验室的代表性批次在转染的胶质母细胞瘤和转染的LN229细胞中检测到异柠檬酸脱氢酶1（IDH1）-R132S（Kaneko，M. K.，et al.（2011）.Biochem Biophys Res Commun.406（4）:608-613.）。
免疫组织化学分析：一个来自独立实验室的代表性批次在间变性和弥漫性星形细胞瘤组织和原发性胶质母细胞瘤组织中检测到异柠檬酸脱氢酶1（IDH1）-R132S（Kato，Y.，et al.（2009）.Biochem Biophys Res Commun.390（3）:547-51）。
免疫组织化学分析：一个来自独立实验室的代表性批次在转染的胶质母细胞瘤和转染的LN229细胞中检测到异柠檬酸脱氢酶1（IDH1）-R132S（Kaneko，M. K.，et al.（2011）.Biochem Biophys Res Commun.406（4）:608-613.）。
Biochem/physiol Actions
该抗体对异柠檬酸脱氢酶1（IDH1）的R132H突变具有特异性。
Disclaimer
除非我们的目录或产品随附的其他公司文件中另有说明，否则我们的产品预期仅用于研究用途，不得用于任何其他目的，包括但不限于未经授权的商业用途、体外诊断用途、离体或体内治疗用途或对人类或动物的任何类型的消费或应用。
General description
异柠檬酸脱氢酶1（IDH1）是一种46 kDa NADP依赖性酶，可催化异柠檬酸脱羧为α-酮戊二酸。IDH1还可能在预防氧化损伤以及蛋白质向过氧化物酶体的穿梭中发挥作用。广泛报道IDH1中的突变导致各种类型的神经胶质瘤。
观测分子量〜90 kDa。异柠檬酸脱氢酶1（IDH1）的计算分子量为47 kDa。但是，使用带有MBP标记的重组异柠檬酸脱氢酶1（IDH1）进行了蛋白质印迹分析。由于MBP的分子量约为42 kDa，因此在约90 kDa处观察到条带
Immunogen
对应于人异柠檬酸脱氢酶1（IDH1）的KLH偶联线性肽。
Physical form
形式：纯化
纯化的小鼠单克隆IgG1κ，溶于含0.1 M Tris-甘氨酸（pH 7.4）、150 mM NaCl和0.05%叠氮化钠的缓冲液中。
纯化蛋白G
Preparation Note
自接收之日起，在2-8°C下可稳定保存1年。
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Victor Ruiz-Rodado et al.
Molecular oncology, 16(9), 1777-1794 (2021-12-03)
Nutritional intervention is becoming more prevalent as adjuvant therapy for many cancers in view of the tumor dependence on external sources for some nutrients. However, little is known about the mechanisms that make cancer cells require certain nutrients from the
Fatih Erdi et al.
Turkish neurosurgery, 28(1), 7-12 (2017-03-28)
To evaluate and compare the expression of thioredoxin reductase 1 (TrxR1) in primary and secondary glioblastoma samples. Surgically resected human glioblastoma samples from 40 patients who underwent surgery at our institution were extracted from their histopathological specimens and divided into
Roberta Soares Faccion et al.
Cellular oncology (Dordrecht), 41(2), 141-157 (2018-01-28)
Diffuse astrocytic tumors are the most frequently occurring primary central nervous system (CNS) tumors. Their histological sub-classification into diffuse astrocytoma (DA), anaplastic astrocytoma (AA) and glioblastoma (GB) is challenging and the available prognostic factors are limited to age and tumor
Natalia J Martinez et al.
Scientific reports, 8(1), 9472-9472 (2018-06-23)
Assessment of the interactions between a drug and its protein target in a physiologically relevant cellular environment constitutes a major challenge in the pre-clinical drug discovery space. The Cellular Thermal Shift Assay (CETSA) enables such an assessment by quantifying the
Irati Hervás-Corpión et al.
Cancers, 13(21) (2021-11-14)
Glioblastoma (GB) is the most aggressive form of glioma and is characterized by poor prognosis and high recurrence despite intensive clinical interventions. To retrieve the key factors underlying the high malignancy of GB with potential diagnosis utility, we combined the
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持